Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

50 results about "Acotiamide Hydrochloride" patented technology

The hydrochloride salt form of acotiamide, a prokinetic agent with gastrointestinal (GI) motility-enhancing activity. Although the exact mechanism by which acotiamide exerts its effect has yet to be fully elucidated, this agent appears to inhibit acetylcholinesterase (AchE), an enzyme responsible for the breakdown of acetylcholine (Ach). Increased Ach concentrations lead to an improvement of gastric emptying and GI motility and eventually to a reduction of dyspepsia symptoms.

Acotiamide hydrochloride medicinal preparation and preparation method thereof

The invention provides an acotiamide hydrochloride medicinal preparation and a preparation method thereof. The acotiamide hydrochloride medicinal preparation comprises acotiamide hydrochloride and/or a hydrate thereof, at least one diluent, at least one disintegrating agent, at least one adhesive and at least one lubricant, the diluent includes a first diluent and is a hydrophilic instant component, and a weight ratio of the hydrophilic instant component to acotiamide hydrochloride and/or the hydrate thereof is 2:5-4:5. The acotiamide hydrochloride medicinal preparation is prepared by introducing a specific proportion of the hydrophilic instant component to a medicinal preparation and by mixing the hydrophilic instant component among the above acotiamide hydrochloride effective component. When the acotiamide hydrochloride medicinal preparation is dissolved and a material accumulation phenomenon appears, an external layer hydrophilic instant auxiliary material is treated as a pore forming agent, and an internal layer hydrophilic instant auxiliary material is treated as capillaries in a raw material with the dissolving of the external layer hydrophilic instant auxiliary material, and can guide a dissolution medium to rapidly enter the raw material in order to increase the dissolution and improve the dissolution speed.
Owner:SHIJIAZHUANG NO 4 PHARMA

Acotiamide hydrochloride trihydrate refining method and acotiamide hydrochloride trihydrate preparation method

ActiveCN105753810AEasy to removeLiquid phase with high purityOrganic chemistryOrganic solventPotassium hydroxide
The invention discloses an acotiamide hydrochloride trihydrate refining method and an acotiamide hydrochloride trihydrate preparation method.The acotiamide hydrochloride trihydrate refining method includes adding crude acotiamide into an inorganic base aqueous solution with uniformly mixing, adding an organic solvent with stirring to crystallize, filtering and drying to obtain acotiamide hydrochloride sodium salt or acotiamide hydrochloride potassium salt, wherein inorganic base refers to sodium hydroxide, potassium hydroxide, sodium carbonate or potassium carbonate; adding the acotiamide hydrochloride sodium salt or acotiamide hydrochloride potassium salt into a hydrous isopropanol solution with uniformly mixing, adding hydrochloric acid to acidize a mixture to a pH value being 1-2, stirring to crystallize, heating to dissolve, decreasing the temperature to crystallize, and performing decompression drying so as to obtain acotiamide hydrochloride trihydrate.The acotiamide hydrochloride trihydrate refining method has the advantages that the acotiamide is prepared into the sodium salt or potassium salt, the sodium salt or potassium salt is refined, and accordingly impurities before and after a main peak can be removed effectively, and the final product, namely the acotiamide hydrochloride trihydrate, is above 99.8% in purity and below 0.10% in individual impurities.
Owner:浙江新赛科药业有限公司

High-performance liquid chromatography analytical method for N1,N1-diisopropyl ethylenediamine

The invention relates to a high-performance liquid chromatography analytical method for N1,N1-diisopropyl ethylenediamine. The analytical method is characterized by including the following steps that 1, N1,N1-diisopropyl ethylenediamine standard solutions of different concentrations are prepared, excess 2,4-dinitrofluorobenzene is added into the standard solutions for a derivatization reaction, after the reaction is completed, high-performance liquid chromatography analysis is carried out on reaction solutions, and the DNB-N1,N1-diisopropyl ethylenediamine peak area corresponds to a N1,N1-diisopropyl ethylenediamine concentration drawing standard curve; 2, a test sample is prepared into a solution, excess 2,4-dinitrofluorobenzene is added into the solution to react, after the reaction is completed, high-performance liquid chromatography analysis is carried out on the reaction solution, and the content of N1,N1-diisopropyl ethylenediamine in the test sample is calculated. The analytical method is accurate, high in repeatability and sensitivity, and capable of being used for detecting N1,N1-diisopropyl ethylenediamine in the producing and placing processes of acotiamide hydrochloride and tablets thereof and detecting N1,N1-diisopropyl ethylenediamine in other samples.
Owner:HANGZHOU XINBOSI BIOMEDICAL CO LTD

Acotiamide hydrochloride sustained-release pellet and preparation method thereof

InactiveCN105476963AEfficient can effectively adjust the release rateEffective regulation of release rateOrganic active ingredientsDigestive systemSustained release pelletsDrug release rate
The invention belongs to the field of medicine, and discloses an acotiamide hydrochloride sustained-release pellet and a preparation method thereof. The acotiamide hydrochloride sustained-release pellet consists of the following components in parts by weight: 2-50 parts of acotiamide hydrochloride, 20-95 parts of a thinner, 1-10 parts of a binding agent, 1-30 parts of a sustained-release material, 0-5 parts of a pore-forming agent, 0-5 parts of a plasticizer, 0-20 parts of an anti-sticking agent and 0-5 parts of a light-screening agent. By mixing the thinner, the binding agent, the sustained-release material and the acotiamide hydrochloride according to certain proportions, a drug release rate can be effectively regulated, and the acotiamide hydrochloride can be slowly released in vivo so as to generate a stable blood concentration and to avoid adverse reactions caused by relatively great fluctuation of the blood concentration in vivo in the case that the acotiamide hydrochloride dissolves rapidly in vivo. The preparation method of the acotiamide hydrochloride sustained-release pellet is simple to operate, low in production cost and high in efficiency, and the preparation method is applicable to the industrial production of the acotiamide hydrochloride sustained-release pellets.
Owner:BEIJING COLLAB PHARMA

Acotiamide hydrochloride controlled release tablet and preparation method thereof

The invention relates to an acotiamide hydrochloride controlled release tablet and a preparation method thereof, and belongs to the field of medical preparations. The controlled release tablet comprises an acotiamide hydrochloride solid dispersion and pharmaceutical excipients, wherein the acotiamide hydrochloride solid dispersion comprises acotiamide hydrochloride, a polymer, a plasticizer and a lubricant b; and the pharmaceutical excipients include a controlled release material, a stabilizer, a disintegrating agent, an adhesive, a lubricant a and a coating material. The preparation method comprises the steps of firstly performing hot-melt extrusion on acotiamide hydrochloride to obtain the acotiamide hydrochloride solid dispersion; secondly adding the solid dispersion to the pharmaceutical excipients to prepare a mixture; thirdly, preparing the mixture into a tablet; and finally preparing the tablet into a coated tablet by using the coating material. According to the scheme, the early release degree of acotiamide hydrochloride is increased, the controlled release effect can last for 24 hours, and the tablet has very high stability; and in addition, the preparation method is simple in process and free of solvent residues, and other impurities are not introduced in the whole process, so that the preparation method is suitable for industrial production.
Owner:JINAN KANGHE MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products